Literature DB >> 34329583

Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.

Prakash Bhuyan1, Jennie Medin2, Hugo Gomes da Silva3, Madhavi Yadavalli4, Nirmal Kumar Shankar5, Hana Mullerova3, Matthew Arnold3, Magnus Nord6.   

Abstract

Entities:  

Year:  2021        PMID： 34329583     DOI： 10.1016/S0140-6736(21)01693-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination.

Authors:  Taylor S Cohen; Elizabeth J Kelly; Sven Nylander; Himanshu Bansal; Brett M Jepson; Prakash Bhuyan; Magdalena E Sobieszczyk; Ann R Falsey
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

2.  Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.

Authors:  Pedro M Folegatti; Daniel Jenkin; Susan Morris; Sarah Gilbert; Denny Kim; James S Robertson; Emily R Smith; Emalee Martin; Marc Gurwith; Robert T Chen
Journal:  Vaccine       Date:  2022-06-14       Impact factor: 4.169

3.  Second-dose VITT: rare but real.

Authors:  Sue Pavord; Michael Makris
Journal:  Blood       Date:  2022-04-28       Impact factor: 25.476

Review 4.  SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health.

Authors:  Mohammad Abdullah Sarkar; Ahmad Ozair; Kaushal Kishor Singh; Nishanth R Subash; Mainak Bardhan; Yashita Khulbe
Journal:  Ann Glob Health       Date:  2021-12-10       Impact factor: 2.462

5.  Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.

Authors:  Karina Soboleva; Nirmal Kumar Shankar; Madhavi Yadavalli; Cátia Ferreira; Nadia Foskett; Kert Putsepp; Lisa Beth Ferstenberg; Magnus Nord; Hugo Gomes da Silva; Prakash Bhuyan
Journal:  Lancet Glob Health       Date:  2022-01       Impact factor: 26.763

6.  Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution.

Authors:  Vijay S Reddy; Xiaodi Yu; Michael A Barry
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

7.  COVID-19 Vaccination Coverage in Patients with Rheumatic Diseases in a German Outpatient Clinic: An Observational Study.

Authors:  Marco Krasselt; Christoph Baerwald; Olga Seifert
Journal:  Vaccines (Basel)       Date:  2022-02-07

8.  Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination.

Authors:  T Langerak; G J Bakker; L Porcelijn; M N Lauw; R J van de Laar; M Eefting
Journal:  Thromb Res       Date:  2022-04-05       Impact factor: 10.407

9.  ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome.

Authors:  Alexander T Baker; Ryan J Boyd; Daipayan Sarkar; Alicia Teijeira-Crespo; Chun Kit Chan; Emily Bates; Kasim Waraich; John Vant; Eric Wilson; Chloe D Truong; Magdalena Lipka-Lloyd; Petra Fromme; Josh Vermaas; Dewight Williams; LeeAnn Machiesky; Meike Heurich; Bolni M Nagalo; Lynda Coughlan; Scott Umlauf; Po-Lin Chiu; Pierre J Rizkallah; Taylor S Cohen; Alan L Parker; Abhishek Singharoy; Mitesh J Borad
Journal:  Sci Adv       Date:  2021-12-01       Impact factor: 14.136

10.  A case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital.

Authors:  Isabella Watts; David Smith; Sarah Mounter; Emma H Baker; Andrew W Hitchings; Dipender Gill
Journal:  Br J Clin Pharmacol       Date:  2021-11-09       Impact factor: 3.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.